Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of Camrelizumab Combined With Apatinib Mesylate in Solid Tumors

NCT05380986 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT05380986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of Camrelizumab Combined With Apatinib Mesylate in Solid Tumors
Lead sponsor
Henan Cancer Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 20, 2022
Completion date
May 1, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor